Table 3. Top 10 most active journals in targeted therapy for renal cancer as measured by the total number of publications from 2006 to 2022.
| Ranking | Journal | Number of Documents | IF | % |
|---|---|---|---|---|
| 1st | Journal of Clinical Oncology | 35 | 50.739 | 3.08 |
| 2nd | Onkourologiya | 32 | Unknown | 2.81 |
| 3rd | Annals of Oncology | 25 | 51.769 | 2.20 |
| 4th | Clinical Genitourinary cancer | 23 | 3.121 | 2.02 |
| 5th | European Urology | 23 | 24.344 | 2.02 |
| 6th | Urologic Oncology Seminars and Original Investigations | 19 | 2.954 | 1.67 |
| 7th | BJU International | 18 | 5.969 | 1.58 |
| 8th | Bulletin Du Cancer | 18 | 1.318 | 1.58 |
| 9th | Clinical Cancer Research | 18 | 13.801 | 1.58 |
| 10th | Journal Of Urology | 18 | 7.641 | 1.58 |
IF (Year 2022), impact factor.